Syros Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Syros Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2015 to Q3 2024.
  • Syros Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 26.8M shares, a 29.5% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 26.8M +6.11M +29.5% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 26.8M +6.1M +29.5% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 26.7M +6.32M +31% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 26.4M +6.19M +30.5% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 20.7M +495K +2.45% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 20.7M -42.3M -67.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 20.4M -42.4M -67.5% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 20.3M +14.1M +227% Dec 31, 2022 10-K 2024-03-27
Q3 2022 20.2M -41.7M -67.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 63M +1.07M +1.73% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 62.8M +952K +1.54% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 6.2M -50M -89% Dec 31, 2021 10-K 2023-03-02
Q3 2021 61.9M +16.1M +35.2% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 61.9M +16.2M +35.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 61.8M +16.2M +35.4% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 56.2M +12.9M +29.6% Dec 31, 2020 10-K 2022-03-15
Q3 2020 45.8M +3.37M +7.93% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 45.8M +3.32M +7.83% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 45.7M +11.9M +35.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 43.4M +9.6M +28.4% Dec 31, 2019 10-K 2021-03-04
Q3 2019 42.4M +8.79M +26.1% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 42.4M +8.81M +26.2% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 33.8M +1.53M +4.75% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 33.8M +7.34M +27.8% Dec 31, 2018 10-K 2020-03-05
Q3 2018 33.7M +7.36M +28% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 33.6M +7.39M +28.2% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 32.2M +8.8M +37.6% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 26.4M +3.04M +13% Dec 31, 2017 10-K 2019-03-07
Q3 2017 26.3M +2.92M +12.5% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 26.2M +23.5M +877% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 23.4M Mar 31, 2017 10-Q 2017-05-15
Q4 2016 23.4M +21M +889% Dec 31, 2016 10-K 2018-03-12
Q3 2016 23.4M Sep 30, 2016 10-Q 2016-11-14
Q2 2016 2.68M Jun 30, 2016 10-Q 2016-08-15
Q4 2015 2.36M Dec 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.